XBiotech (XBIT) Accumulated Expenses (2014 - 2026)
XBiotech's Accumulated Expenses came in at $2.25 million for Q2 2026, down 6.7% from $2.41 million a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, XBiotech's Accumulated Expenses was $6.32 million, up 140.0% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 36.1% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $2.63 million in FY2024 (-24.8%), $3.5 million in FY2023 (+118.4%), $1.6 million in FY2022 (+16.7%) and $1.37 million in FY2021 (+1.7%).
- The Q2 2026 figure represents the lowest quarterly Accumulated Expenses since Q1 2023.
- Year-over-year, Accumulated Expenses increased in three of the last seven quarters, with growth averaging 4.6%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q2 2022 (growth of 232.4%), and the weakest in Q2 2025 (a decline of 54.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | XBiotech | 66.77 Mn | 66.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.25 Mn |
| Dec 31, 2025 | 6.32 Mn |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 2.41 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 4.49 Mn |
| Jun 30, 2024 | 5.35 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Sep 30, 2023 | 3.67 Mn |
| Jun 30, 2023 | 2.63 Mn |
| Mar 31, 2023 | 2.21 Mn |
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 5.59 Mn |
| Mar 31, 2022 | 1.57 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 1.64 Mn |
| Jun 30, 2021 | 1.68 Mn |
API Access
XBiotech Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();